New drug:
"CNM-Au8 is an orally administered gold nanocrystal suspension" It's labeled as a remyelinating agent. The company is based in Salt Lake City, where my neurologist's practice is. I wonder if anything works when there's scar tissue that has replaced myelin.
New drug?
Re: New drug?
Here's the company's web site.koneall wrote:"CNM-Au8 is an orally administered gold nanocrystal suspension" It's labeled as a remyelinating agent. The company is based in Salt Lake City, where my neurologist's practice is. I wonder if anything works when there's scar tissue that has replaced myelin.
http://clene.com/index.html
It looks like they recently finished a phase I trial and are about to start a phase II trial.
https://clinicaltrials.gov/ct2/show/NCT02755870
http://www.pharmabiz.com/NewsDetails.as ... 7107&sid=2
Re: New drug?
Just finished phase II trial with promising results:
https://www.abstractsonline.com/pp8/#!/ ... tation/269
https://www.abstractsonline.com/pp8/#!/ ... tation/269
ACTRIMS 2024: 2 treatments to aid remyelination
Two treatments to aid remyelination near clinical trials
CVL-1001 inhibits EBP protein
CVL-2001 blocks the activity of CYP51
https://multiplesclerosisnewstoday.com/ ... qmUTPSeU58
CVL-1001 inhibits EBP protein
CVL-2001 blocks the activity of CYP51
https://multiplesclerosisnewstoday.com/ ... qmUTPSeU58
-
- Similar Topics
- Replies
- Views
- Last post